Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection

被引:34
|
作者
Kuster, H [1 ]
Opravil, M
Ott, P
Schlaepfer, E
Fischer, M
Günthard, HF
Lüthy, R
Weber, R
Cone, RW
机构
[1] Univ Zurich Hosp, Div Infect Dis, Dept Internal Med, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Policlin Ear Nose Throat & Face Surg, CH-8091 Zurich, Switzerland
来源
AMERICAN JOURNAL OF PATHOLOGY | 2000年 / 156卷 / 06期
关键词
D O I
10.1016/S0002-9440(10)65070-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report detailed quantitative analysis of human immunodeficiency virus-1 (HIV-1) p24 and HIV-1 RNA in tonsil biopsies from 13 patients with early, asymptomatic HIV infection before and during combination antiretroviral therapy. Using fluorescent microscopy in conjunction with reverse transcriptase-polymerase chain reaction of frozen tissue sections, we show that plasma and tissue viral loads decreased by approximately 3 logs during the 1-year treatment period, with good correlation between the HIV-1 p24 and HIV-1 RNA response in tissue. The decrease of tissue viral load was delayed compared to plasma viral load, possibly explained by the observation that the amount of follicular dendritic cell-associated virus correlated best with the area under the curve of plasma HIV-1 RNA throughout the last 12 weeks. Before and during treatment, the relative proportions of HIV-1 on follicular dendritic cells and within mononuclear cells remained constant, suggesting similar decay characteristics in these two lymphoid tissue compartments. However, viral p24 or RNA remained almost always detectable in tissue despite full suppression of HIV-1 RNA in plasma, and increased even after short-term rebounds in plasma viral load. Thus, full and sustained suppression of viral replication was required to efficiently decrease viral load in lymphoid tissue, but complete abolition of residual viral replication was not achieved.
引用
收藏
页码:1973 / 1986
页数:14
相关论文
共 50 条
  • [1] HYPOCHOLESTEROLEMIA AND HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) INFECTION
    DURSUN, SM
    REVELEY, MA
    AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05): : 518 - 518
  • [2] HYPOCHOLESTEROLEMIA AND HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) INFECTION - REPLY
    SHORPOSNER, G
    LU, Y
    FLETCHER, M
    BAUM, MK
    AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05): : 519 - 520
  • [3] Inactivation and purification of human immunodeficiency virus-1 as antigen for the treatment of HIV-1 infection
    Prior, CP
    Gore, R
    Harter, J
    Berbaum, M
    Duffy, C
    Ferre, F
    Hancock, R
    Lowry, P
    Musil, R
    Stiglitz, M
    Carlo, DJ
    Richieri, SP
    Maigetter, RZ
    BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS, 1996, 9 (09): : 22 - &
  • [4] THROMBOCYTOPENIA AND HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    WALSH, CM
    KARPATKIN, S
    SEMINARS IN ONCOLOGY, 1990, 17 (03) : 367 - 374
  • [5] Surgery and human immunodeficiency virus-1 infection
    Wastell, C
    Corless, D
    Keeling, N
    AMERICAN JOURNAL OF SURGERY, 1996, 172 (01): : 89 - 92
  • [6] NEUROPATHOLOGY OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
    HENIN, D
    HAUW, JJ
    PRESSE MEDICALE, 1988, 17 (40): : 2129 - 2133
  • [7] NASOPHARYNGEAL LYMPHOID-TISSUE MASSES IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-1
    CARBONE, A
    GLOGHINI, A
    VACCHER, E
    BARZAN, L
    TIRELLI, U
    CANCER, 1995, 76 (03) : 527 - 528
  • [8] ACTIVATION OF HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) BY DNA DEMETHYLATION
    OBRIEN, MC
    MITSUYA, H
    CLINICAL RESEARCH, 1991, 39 (02): : A220 - A220
  • [9] LOW PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1), HIV-2, AND HUMAN T-CELL LYMPHOTROPIC VIRUS-1 INFECTION IN SOMALIA
    SCOTT, DA
    CORWIN, AL
    CONSTANTINE, NT
    OMAR, MA
    GULED, A
    YUSEF, M
    ROBERTS, CR
    WATTS, DM
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 45 (06): : 653 - 659
  • [10] Closing in on human immunodeficiency virus-1
    Mellors, JW
    NATURE MEDICINE, 1996, 2 (03) : 274 - 275